Modi AC, Ingerski LM, Rausch JR, Glauser TA. Treatment Factors Affecting Longitudinal Quality of Life in New Onset Pediatric Epilepsy.J Pediatr Psychol. 2011 Jan 29.
Herzer M, Zeller MH, Rausch JR, Modi AC. Perceived Social Support and Its Association With Obesity-Specific Health-Related Quality of Life.J Dev Behav Pediatr. 2011 Jan 21.
Modi AC, Driscoll KA, Montag-Leifling K, Acton JD. Screening for symptoms of depression and anxiety in adolescents and young adults with cystic fibrosis. Pediatr Pulmonol. 2011 Feb;46(2):153-9. doi: 10.1002/ppul.21334.
Modi AC, Guilfoyle SM, Morita DA, Glauser TA. Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy.Epilepsia. 2011 Feb;52(2):370-6. doi: 10.1111/j.1528-1167.2010.02789.x.
Modi AC, Driscoll KA, Montag-Leifling K, Acton JD. Screening for symptoms of depression and anxiety in adolescents and young adults with cystic fibrosis. Pediatr Pulmonol. 2010 Nov 17.
Modi AC, Zeller MH. The IWQOL-Kids<sup>©</sup>: Establishing minimal clinically important difference scores and test-retest reliability.Int J Pediatr Obes. 2010 Sep 30.
Modi AC, Quittner AL, Boyle MP. Assessing disease disclosure in adults with cystic fibrosis: the Adult Data for Understanding Lifestyle and Transitions (ADULT) survey Disclosure of disease in adults with cystic fibrosis.BMC Pulm Med. 2010 Sep 10;10:46.
Modi AC, Monahan S, Daniels D, Glauser TA. Development and validation of the Pediatric Epilepsy Medication Self-Management Questionnaire. Epilepsy Behav. 2010 May;18(1-2):94-9.
Modi AC, Cassedy AE, Quittner AL, Accurso F, Sontag M, Koenig JM, Ittenbach RF. Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis.J Pediatr Psychol. 2010 Oct;35(9):1028-37.
Modi AC, Lim CS, Driscoll KA, Piazza-Waggoner C, Quittner AL, Wooldridge J. Changes in pediatric health-related quality of life in cystic fibrosis after IV antibiotic treatment for pulmonary exacerbations.J Clin Psychol Med Settings. 2010 Mar;17(1):49-55.